ClinicalTrials.gov
ClinicalTrials.gov Menu

Visual Acuity and Optical Coherence Tomography One Year After Peeling of Epiretinal Membranes

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03583632
Recruitment Status : Recruiting
First Posted : July 11, 2018
Last Update Posted : July 11, 2018
Sponsor:
Information provided by (Responsible Party):
Prim. Prof. Dr. Oliver Findl, MBA, Vienna Institute for Research in Ocular Surgery

Brief Summary:
Improvement in visual acuity and retinal anatomy one year after surgery is assessed and compared to data preoperative and 3 months after surgery

Condition or disease Intervention/treatment
Epiretinal Membrane Other: visual acuity testing Device: optical coherence tomography

Detailed Description:
Improvement in visual acuity and retinal anatomy (documented by optical coherence tomography) one year after surgery is assessed and compared to data preoperative and 3 months after surgery. Aim of the study is to examine possible improvements of surgical outcomes in the period up to the one year follow-up.

Study Type : Observational
Estimated Enrollment : 20 participants
Observational Model: Case-Control
Time Perspective: Other
Official Title: Visual Acuity and Optical Coherence Tomography One Year After Peeling of Epiretinal Membranes
Actual Study Start Date : February 1, 2018
Estimated Primary Completion Date : December 31, 2019
Estimated Study Completion Date : December 31, 2019

Intervention Details:
  • Other: visual acuity testing
    testing of visual ycuity by ETDRS charts
  • Device: optical coherence tomography
    optical coherence tomography generates sectional slides of the retinal tomography with light


Primary Outcome Measures :
  1. visual acuity [ Time Frame: 3 minutes ]
    visual acuity testing with EDTRS charts


Secondary Outcome Measures :
  1. optical coherence tomography [ Time Frame: 3 minutes ]
    optical coherence tomography generates slides of the retinal anatomy with light



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Sampling Method:   Non-Probability Sample
Study Population
For this study only patients after vitrectomy with Membrane Peeling due to epiretinal membranes are selected
Criteria

Inclusion Criteria:

  • vitrectomy with Membrane Peeling due to an epiretinal membrane

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03583632


Contacts
Contact: Oliver Findl, MD, Prof +43 1 91021-84611 oliver@findl.at

Locations
Austria
Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna Recruiting
Vienna, Austria, 1140
Contact: Oliver Findl, MD, Prof         
Sponsors and Collaborators
Vienna Institute for Research in Ocular Surgery
Investigators
Principal Investigator: Oliver Findl, MD, Prof VIROS at Hanuschkrankenhaus Vienna

Responsible Party: Prim. Prof. Dr. Oliver Findl, MBA, Prof. Dr. Oliver Findl, MBA, FEBO, Vienna Institute for Research in Ocular Surgery
ClinicalTrials.gov Identifier: NCT03583632     History of Changes
Other Study ID Numbers: ERM 1year follow-up
First Posted: July 11, 2018    Key Record Dates
Last Update Posted: July 11, 2018
Last Verified: June 2018

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Epiretinal Membrane
Retinal Diseases
Eye Diseases